Follicle stimulating hormone biosimilar (InSight Biopharmaceuticals)

促卵泡激素生物类似药 (InSight Biopharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFollicle stimulating hormone biosimilar (InSight Biopharmaceuticals)
Drug Alias Name促卵泡激素生物仿制药 (InSight Biopharmaceuticals)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2015/11/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInsight Biopharmaceuticals
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInfertility, Female
Inactive IndicationsN/A

Other Information

ATC CodeG03GA05G03GA06G03GA10
Related LinksN/A